Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to substitute silicone implants.
TENSIVE has raised $14.6M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
TENSIVE's investors include UniCredit, European Innovation Council, Panakes Partners, Invitalia Ventures, EISMEA.
TENSIVE is headquartered in Milano, Italy.
Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to substitute silicone implants.
TENSIVE is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TENSIVE — Funding & Investors." VCBacked, January 29, 2025, https://www.vcbacked.co/company/tensive. Accessed July 19, 2026.
VCBacked. (2025). TENSIVE — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tensive
{{cite web |title=TENSIVE — Funding & Investors |url=https://www.vcbacked.co/company/tensive |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated